top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato actin
active targeting
acute toxicity
adsorption
albumin
albumin nanoparticle
albumin nanoparticles
anacardic acid
angiogenesis
anti-cancer
anti-metastatic enzyme cancer therapy
anti-topoisomerase activity
anti-tumor immunity
antibody drug conjugate (ADC)
anticancer and antibacterial activity
antitumor strategy
apoptosis
ascorbic acid
BALB-neuT mice
biodistribution
biomimetic
biomimetic core-shell nanoparticles
biomimicry
bleeding
blood brain barrier
brain tumours
breast cancer
cabazitaxel
cancer
cancer diagnosis
cancer nanomedicine
cancer therapy
cathepsin D
cathepsin L
cats
cell signaling
cellular interaction
cellular microenvironment
chemico-physical functionalization
chemotherapeutics
chirality separation
clinical status
clinical translation
collagen
colloidal stability
colorectal carcinoma
combinatorial therapy
copper
CPMV
CSCs
cyclodextrins
cytotoxicity
diagnostics
differentiated neuroblastoma
dioleoylphosphatidylethanolamine
DNA origami
docetaxel
dogs
DOX
doxorubicin
drug combination
drug delivery
drug delivery system
drug-gene delivery
drug-in-cyclodextrin-in-liposome
dual-targeting
epithelial-to-mesenchymal transition
EPR effect
erlotinib
everolimus
exosomes
extracellular vesicles
FA-DABA-SMA
flow
folate
folate receptor
folic receptor alpha
glioblastoma
glioma
gold nanoparticles
gold nanorods
graphene oxide
hepatocellular carcinoma
hyaluronic acid
hyaluronidase
hybrid nanoparticles
hyperthermia
hyperthermia therapy
hypoxia
imaging
immune modulation
immunosuppression
immunotherapy
Immunotherapy
in situ vaccine
in vitro
in vitro anti-cancer activity
integrin
intra-arterial chemotherapy
intracellular disruption
intracranial glioma
iron affinity
lanthanide metal
ligand
lipid nanoparticles
liposome
liposomes
loading
lung cancer
lymphadenectomy
magnetic actuation
magnetic drug targeting
magnetic hyperthermia
magnetic nanoparticles
magnetic nanowires
magnetic silica-coated iron oxide nanochains
magnetometer
mammary carcinoma
mangiferin
MDA-MB-231
melanoma
membrane-wrapped
mesenchymal stem cells (MSCs)
Mesoporous silica nanoparticle
mesoporous silica nanoparticles
metabolism
microbubble
microfluidic
mitoxantrone
mixed micelle
molecular imaging
monoclonal antibodies
multicellular tumor spheroids
nano-bio interactions
nano-engineered MSCs
nanobiotechnology
nanocarrier
nanomedicine
nanomedicines
nanomicelles
nanoparticle
nanoparticles
nanostructured lipid carrier
nanosystems
nanotechnology: bioengineering
nanotherapeutics
NASH
near IR hyperspectral imaging
NK cell-derived exosomes
oncogenes
oncogenic proteins
organoids
organotin
orthotopic lung tumor model
osteopontin
ovarian cancer
ovarian carcinomatosis
oxidation-sensitive release
paclitaxel
pancreatic cancer
parvifloron D
passive targeting
PD-L1
PEGylation
peptidomimetics
pH responsive
photodynamic therapy
photodynamic therapy article
photothermal therapy
photothermal treatment
plasmonic photothermal therapy
plasmonics
platelet membrane
PLGA
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
polydopamine nanoparticles
polymeric nanoconstruct
polymeric nanoparticles
prostate cancer
radiotherapy
real-time quantitative polymerase chain reaction (qPCR)
remote loading
RGD peptide
riboflavin
secondary structure
self-assembly
sentinel lymph node dissection
shear stress
single-walled carbon nanotubes
siRNA
size
SN38
spheroids
SPION
stimuli-responsive
superparamagnetic iron oxide nanoparticles
surgery
target treatment
targeted delivery
targeted delivery system
targeted drug delivery
targeted therapy
TAT peptide
temoporfin
theranostic nanomaterials
theranostics
therapeutics
titanate nanotubes
translational medicine
triple negative breast cancer
tumor microenvironment
tumor spheroid disruption
tumor targeting
tumor vectorization
tumour microenvironment
tumour targeting
ultrasound
vectorization
VEGF
verteporfin
viral nanoparticles
vitamin B2
VX2 tumor
Vδ2 T cells
yet reasonably common within the subject discipline
zoledronic acid
β-cyclodextrin nanosponges
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Computational and Experimental Approaches in Multi-Target Pharmacology
Computational and Experimental Approaches in Multi-Target Pharmacology
Autore Anastasio Thomas J
Pubbl/distr/stampa Frontiers Media SA, 2017
Descrizione fisica 1 online resource (122 p.)
Collana Frontiers Research Topics
Soggetto topico Pharmacology
Soggetto non controllato computer modeling
drug combination
drug discovery
drug repurposing
high throughput screening
multidrug therapeutics
multifactorial process
polypharmacy
synergy
systems biology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910261143503321
Anastasio Thomas J  
Frontiers Media SA, 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
In Vitro and In Vivo Models of Colorectal Cancer for Clinical Application
In Vitro and In Vivo Models of Colorectal Cancer for Clinical Application
Autore Baiocchi Marta
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (222 p.)
Soggetto topico Biology, life sciences
Microbiology (non-medical)
Research & information: general
Soggetto non controllato 3D bioprinting
animal models
cancer stem cell methods
cancer stem cells
cancer-on-chip
CDX2
chromosomal instability
circulating tumor cells
clinical translation study
clinical trials
colon cancer
colorectal cancer
colorectal carcinoma
CRC
CTC cluster
decitabine
DNA damage
DNA methylation
drug combination
drug resistance
epithelial mesenchymal transition
HIF-1α
histological examination
hypoxia
immunofluorescence analysis
immunotherapy
in vitro culture
machine learning
methods
mutation analysis
organoids
patient-derived cancer models
patient-derived tumor organoid
patient-derived xenograft
PDX model
precision medicine
prognosis
radiation response
rectal cancer
SATB2
ScreenCell®
sequential filtration
single-cell RNA-sequencing
size-based method
targeted therapy
transcriptional programs
tumor cell differentiation
tumor heterogeneity
tumor metabolism
tumor-initiating cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585944103321
Baiocchi Marta  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Tuberculosis Drug Discovery and Development 2019
Tuberculosis Drug Discovery and Development 2019
Autore Riccardi Giovanna
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (296 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato anti-TB drug pipeline
anti-virulence compounds
antibiotic
antimicrobial drug resistance (AMR)
antimycobacterial
antituberculosis agents
artificial pneumothorax
BCG
bedaquiline
biomarkers
Carlo Forlanini
caseum
cell envelope
clinical studies
clinical trial
CTVD
delpazolid
discovery
DNA gyrase
dormancy
DprE1 inhibitor
drug combination
drug development
drug discovery
drug resistance
drug-drug interactions
EDCTP
electron transport chain
energy metabolism
genomics
granulomas
host-directed therapy
IAVI
in vitro
in vivo
isoniazid
lead generation
lipidomics
macozinone
mechanism of action
mechanisms of resistance
metabolomics
MID3
mode of action
multi-drug resistance
mutations
mycobacteria
mycobacterium
Mycobacterium tuberculosis
n/a
oxidative phosphorylation
pharmacodynamics
pharmacokinetics
phenotypic screening
PknB
PknG
post-treatment sequelae
privileged targets
promiscuous targets
proteomics
pulmonary rehabilitation
Q203
rifampin
structure-based drug design
surgery
target
target identification
target-based drug design
target-based screening
TB
TBVI
toxicity
transcriptomics
tuberculosis
tuberculosis treatment
tuberculosis vaccines
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557627203321
Riccardi Giovanna  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui